Literature DB >> 32184731

Corrigendum: Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice.

Amit S Choudhari1, Pallavi C Mandave2, Manasi Deshpande3, Prabhakar Ranjekar4, Om Prakash5,6.   

Abstract

[This corrects the article DOI: 10.3389/fphar.2019.01614.].
Copyright © 2020 Choudhari, Mandave, Deshpande, Ranjekar and Prakash.

Keywords:  anticancer; clinical; medicinal plants; phytochemicals; preclinical

Year:  2020        PMID： 32184731      PMCID： PMC7058694          DOI： 10.3389/fphar.2020.00175

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN： 1663-9812            Impact factor:   5.810


In the original article, – were matched with the wrong legends. The correct figures, with their legends, appear below.
Figure 1

Chemical structures of some anticancer phytochemicals in preclinical trials.

Figure 3

Chemical structures of some anticancer agents in clinical use.

Chemical structures of some anticancer phytochemicals in preclinical trials. Chemical structures of some anticancer agents in clinical trials. Chemical structures of some anticancer agents in clinical use. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
  2 in total

1.  Protective Effect of Methanolic Extract of Euglena tuba Against Dalton Lymphoma Induced Oxidative Stress in BALB/c Mice.

Authors:  Swati Prabha Gupta; Priyanka Tiwari; Bechan Sharma
Journal:  Indian J Clin Biochem       Date:  2021-10-20

2.  Integrated analysis and identification of nine-gene signature associated to oral squamous cell carcinoma pathogenesis.

Authors:  Monika Yadav; Dibyabhaba Pradhan; Rana P Singh
Journal:  3 Biotech       Date:  2021-04-14       Impact factor: 2.406
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.